Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Russian biotech VC and Quintiles to join forces on pharma services startups
Russian biotech VC and Quintiles to join forces on pharma services startups
Fierce Biotech
Quintiles
Russia
venture capital
Russian Venture Company
New Zelboraf data shows big survival boost
New Zelboraf data shows big survival boost
Fierce Pharma
Zelboraf
melanoma
Roche
How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch
How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch
Minyanville
earnings
Dendreon
Agenus
Galena Biopharma
ImmunoCellular
Roche seen extending Illumina offer at same price
Roche seen extending Illumina offer at same price
Reuters
Roche
Illumina
M&A
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Seeking Alpha
Qnexa
Vivus
obesity
Arena Pharmaceuticals
Orexigen
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
PDL Biopharma
earnings
Buy, Sell, or Hold: Keryx Pharmaceuticals
Buy, Sell, or Hold: Keryx Pharmaceuticals
Motley Fool
Keryx
colorectal cancer
Zerenex
perifosine
kidney failure
Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance
Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance
Yahoo
Endo
earnings
Warner Chilcott sees restructuring complete in 2012, to impact 500 employees
Warner Chilcott sees restructuring complete in 2012, to impact 500 employees
Yahoo/Fly on the Wall
Warner Chilcott
restructuring
layoffs
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Forbes
vaccines
Novartis
Menveo
Bexsero
meningococcal disease
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »